GlaxoSmithKline ( GlaxoSmithKline )

GlaxoSmithKline

GlaxoSmithKline's picture

GlaxoSmithKline started operations on 1 January 2001 following the merger of GlaxoWellcome plc and SmithKline Beecham plc, but our combined histories go back much further than that. Find out about the many products and mergers that led to the GSK we know today.

GlaxoSmithKline press release, blog etc

04/18/2018 - 15:59 Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD
04/18/2018 - 08:15 GSK appoints Kevin Sin as new SVP and Head of Worldwide Business Development for R&D
04/12/2018 - 01:36 GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
03/27/2018 - 00:37 GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
03/23/2018 - 04:10 ViiV Healthcare gains CHMP positive opinion for Juluca (dolutegravir/rilpivirine) in Europe
03/23/2018 - 02:05 GSK update regarding Pfizer Inc. Consumer Healthcare
03/23/2018 - 01:09 Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over
03/20/2018 - 05:46 GSK starts phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
03/08/2018 - 03:42 GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma
03/06/2018 - 04:23 New clinical data demonstrate high vaccine efficacy of Fluarix Tetra (Influenza Vaccine) in children 6-35 months of age
03/05/2018 - 13:02 ViiV Healthcare announces positive new dolutegravir data for the treatment of people living with HIV co-infected with tuberculosis
03/05/2018 - 07:44 Nucala (mepolizumab) improved asthma control in patients uncontrolled on Xolair (omalizumab)
02/15/2018 - 02:45 GSK receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months and older
02/14/2018 - 05:27 GSK submits landmark IMPACT data to European Medicines Agency to support expanded label for Trelegy Ellipta
02/08/2018 - 07:09 ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment
02/07/2018 - 09:32 ViiV Healthcare files patent infringement litigation against Gilead Sciences Inc. over bictegravir
02/07/2018 - 04:32 GSK delivers improvements in sales, margins and cash flow in 2017
02/07/2018 - 03:45 GSKs meningitis B vaccine Bexsero receives Breakthrough Therapy Designation from US FDA for prevention of Invasive Meningococcal Disease in children 2-10 years of age